The therapeutic potential of epigenetic manipulation during infectious diseases

Pharmacology and Therapeutics

Volumn 167, Issue , 2016, Pages 85-99

  Cole, Joby ^a,b,c   Morris, Paul ^a,b   Dickman, Mark J ^c   Dockrell, David H ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Chromatin; Epigenetic; Immune regulation

Indexed keywords

CRISPR ASSOCIATED PROTEIN; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIINFECTIVE AGENT; HISTONE;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENETICS; GENE EXPRESSION; GENETIC MANIPULATION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; LATENT PERIOD; MACROPHAGE; MACROPHAGE ACTIVATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; SEPSIS; VIRUS INFECTION; ANIMAL; BACTERIAL INFECTIONS; DRUG DESIGN; GENETIC EPIGENESIS; GENETICS; HIV INFECTIONS; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; BACTERIAL INFECTIONS; DRUG DESIGN; EPIGENESIS, GENETIC; HISTONES; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; MACROPHAGES; SEPSIS;

EID: 84981731363     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.07.013     Document Type: Article

References (176)

1. Aberdein, J.D., Cole, J., Bewley, M.A., Marriott, H.M., Dockrell, D.H., Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing. Clin Exp Immunol 174 (2013), 193–202, 10.1111/cei.12170.
2. Allman, D., Pillai, S., Peripheral B cell subsets. Curr Opin Immunol 20 (2008), 149–157, 10.1016/j.coi.2008.03.014.
3. Álvarez-Errico, D., Vento-Tormo, R., Sieweke, M., Ballestar, E., Epigenetic control of myeloid cell differentiation, identity and function. Nat Rev Immunol 15:1 (2014), 7–17, 10.1038/nri3777.
4. Andrews, T., Tran, N., Fairlie, P., Towards histone deacetylase inhibitors as new antimalarial drugs. Curr Pharm Des 18:24 (2012), 3467–3479, 10.2174/138161212801327257.
5. Angus, D.C.M., Wax, R.S.M., Epidemiology of sepsis: an update. [Review]. Crit Care Med, 29, 2001.
6. Anthony, R.M., Urban, J.F., Alem, F., Hamed, H.A., Rozo, C.T., Boucher, J.-L., et al. Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 12 (2006), 955–960, 10.1038/nm1451.
7. Archin, N.M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., Margolis, D.M., Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retrovir 25:2 (2009), 207–212.
8. Archin, N.M., Keedy, K.S., Espeseth, A., Dang, H., Hazuda, D.J., Margolis, D.M., Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS (London, England) 23:14 (2009), 1799–1806.
9. Archin, N.M., Bateson, R., Tripathy, M.K., Crooks, A.M., Yang, K., Dahl, N.P., et al. HIV-1 expression within resting CD4 + T cells after multiple doses of vorinostat. J Infect Dis 210:5 (2014), 728–735.
10. Archin, N.M., Eron, J., Palmer, S., Hartmann-Duff, A., Martinson, J.A., Wiegand, A., et al. Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4 + T cells. AIDS (London, England) 22:10 (2008), 1131–1135.
11. Archin, N.M., Liberty, A.L., Kashuba, A.D., Choudhary, S.K., Kuruc, J.D., Crooks, A.M., et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487:7408 (2012), 482–485.
12. Archin, N.M., Sung, J.M., Garrido, C., Soriano-Sarabia, N., Margolis, D.M., Eradicating HIV-1 infection: seeking to clear a persistent pathogen. Nat Publishing Group 12:11 (2014), 750–764.
13. Ariffin, J.K., Gupta, K.d., Kapetanovic, R., Iyer, A., Reid, R.C., Fairlie, D.P., Sweet, M.J., Histone deacetylase inhibitors promote mitochondrial reactive oxygen species production and bacterial clearance by human macrophages. Antimicrob Agents Chemother, 2015, 10.1128/AAC.01876-15 01876-15.
14. Arts, E.J., Hazuda, D.J., HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med, 2, 2012, 10.1101/cshperspect.a007161.
15. Barneda-Zahonero, B., Román-González, L., Collazo, O., Rafati, H., Islam, A.B.M.M.K., Bussmann, L.H.,.. Parra, M., HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages. PLoS Genet, 9(5), 2013, e1003503, 10.1371/journal.pgen.1003503.
16. Bending, D., De la Peña, H., Veldhoen, M., Phillips, J.M., Uyttenhove, C., Stockinger, B., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119 (2009), 565–572, 10.1172/JCI37865.
17. Berger, S.L., Kouzarides, T., Shiekhattar, R., Shilatifard, A., An operational definition of epigenetics. Genes Dev 23 (2009), 781–783, 10.1101/gad.1787609.
18. Bierne, H., Hamon, M., Cossart, P., Epigenetics and bacterial infections. Cold Spring Harb Perspect Med, 2(12), 2012, 10.1101/cshperspect.a010272.
19. Blazkova, J., Chun, T.-W., Belay, B.W., Murray, D., Justement, J.S., Funk, E.K., et al. Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy. J Infect Dis 206:5 (2012), 765–769.
20. Blazkova, J., Murray, D., Justement, J., Funk, E., Nelson, A.K., Moir, S., et al. Paucity of HIV DNA methylation in latently infected, resting CD4 + T cells from infected individuals receiving antiretroviral therapy. J Virol 86:9 (2012), 5390–5392.
21. Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., et al. CpG methylation controls reactivation of HIV from latency T. J. Hope, ed. PLoS Pathog, 5(8), 2009 pp. e1000554–14.
22. Bocker, M.T., Hellwig, M., Breiling, A., Eckstein, V., Ho, A.D., Lyko, F., Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging. Blood 117: e182–e189. Blood 117:19 (2011), e182–e189, 10.1182/blood-2011-01-331926.
23. Chan, C.H., Fang, C., Qiao, Y., Yarilina, A., Prinjha, R.K., Ivashkiv, L.B., BET bromodomain inhibition suppresses transcriptional responses to cytokine-Jak–STAT signaling in a gene-specific manner in human monocytes. Eur J Immunol 45 (2015), 287–297, 10.1002/eji.201444862.
24. Chang, B., Chen, Y., Zhao, Y., Bruick, R.K., JMJD6 is a histone arginine demethylase. Science 318 (2007), 444–447, 10.1126/science.1145801.
25. Chang, J.T., Wherry, E.J., Goldrath, A.W., Molecular regulation of effector and memory T cell differentiation. Nat Immunol 15:12 (2014), 1104–1115, 10.1038/ni.3031.
26. Chen, J., Li, Q., Life and death of transcriptional co-activator p300. Epigenetics 6 (2011), 957–961, 10.4161/epi.6.8.16065.
27. Chen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J.,.. Natoli, G., Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci 109:42 (2012), E2865–E2874, 10.1073/pnas.1121131109.
28. Chen, G., Shaw, M.H., Kim, Y.-G., Nuñez, G., NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 4 (2009), 365–398, 10.1146/annurev.pathol.4.110807.092239.
29. Cheng, X., Liu, Z., Liu, B., Zhao, T., Li, Y., Alam, H.B., Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model. J Surg Res 197 (2015), 39–44, 10.1016/j.jss.2015.02.070.
30. Cheng, S.C., Quintin, J., Cramer, R.A., Shepardson, K.M., Saeed, S., Kumar, V., et al. mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity. Science, 345, 2014, 1250684, 10.1126/science.1250684.
31. Chun, T.-W., Nickle, D.C., Justement, J.S., Large, D., Semerjian, A., Curlin, M.E., et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest 115:11 (2005), 3250–3255.
32. Clark, I.A., Allison, A.C., Cox, F.E., Protection of mice against Babesia, and Plasmodium with BCG. Nature 259 (1976), 309–311, 10.1038/259309a0.
33. Collins, P.L., Kyle, K.E., Egawa, T., Shinkai, Y., Oltz, E.M., The histone methyltransferase SETDB1 represses endogenous and exogenous retroviruses in B lymphocytes. Proc Natl Acad Sci U S A 112:27 (2015), 8367–8372, 10.1073/pnas.1422187112.
34. Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J.,.. Jaenisch, R., Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107:50 (2010), 21931–21936, 10.1073/pnas.1016071107.
35. Cuddapah, S., Barski, A., Zhao, K., Epigenomics of T cell activation, differentiation and memory. Curr Opin Immunol 22 (2010), 341–347, 10.1016/j.coi.2010.02.007.
36. Daigneault, M., Preston, J.A., Marriott, H.M., Whyte, M.K.B., Dockrell, D.H., The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One, 5, 2010, e8668, 10.1371/journal.pone.0008668.
37. Dalton, D.K., Pitts-Meek, S., Keshav, S., Figari, I.S., Bradley, A., Stewart, T.A., Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259 (1993), 1739–1742.
38. Dawson, M.A., Prinjha, R.K., Dittman, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478 (2011), 529–533, 10.1038/nature10509.
39. De Santa, F., Narang, V., Yap, Z.H., Tusi, B.K., Burgold, T., Austenaa, L., et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J 28 (2009), 3341–3352, 10.1038/emboj.2009.271.
40. DeBerardinis, R.J., Lum, J.J., Hatzivassiliou, G., Thompson, C.B., The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7 (2008), 11–20, 10.1016/j.cmet.2007.10.002.
41. Deeks, S.G., HIV: shock and kill. Nature 487:7408 (2012), 439–440.
42. Deeks, S.G., Autran, B., Berkhout, B., Benkirane, M., Cairns, S., Chomont, N., et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 12:8 (2012), 607–614.
43. Delmore, J.E., Issa, G.C., Lemieux, M.E., Rahl, P.B., Shi, J., Jacobs, H.M., et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146 (2011), 904–917, 10.1016/j.cell.2011.08.017.
44. Dillon, S.C., Zhang, X., Trievel, R.C., Cheng, X., The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol, 6(8), 2005, 227, 10.1186/gb-2005-6-8-227.
45. Ding, S.-Z., Fischer, W., Kaparakis-Liaskos, M., Liechti, G., Merrell, D.S., Grant, P.A., et al. Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS One, 5, 2010, e9875, 10.1371/journal.pone.0009875.
46. DiSpirito, J.R., Shen, H., Histone acetylation at the single-cell level: a marker of memory CD8 + T cell differentiation and functionality. J Immunol 184 (2010), 4631–4636, 10.4049/jimmunol.0903830.
47. Dockrell, D.H., Whyte, M.K.B., Mitchell, T.J., Pneumococcal pneumonia: mechanisms of infection and resolution. Chest 142 (2012), 482–491, 10.1378/chest.12-0210.
48. Durrant, W.E., Dong, X., Systemic acquired resistance. Annu Rev Phytopathol 42 (2004), 185–209, 10.1146/annurev.phyto.42.040803.140421.
49. Ehrt, S., Schnappinger, D., Bekiranov, S., Drenkow, J., Shi, S., Gingeras, T.R., et al. Reprogramming of the macrophage transcriptome in response to interferon-γ and mycobacterium tuberculosis signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194 (2001), 1123–1140, 10.1084/jem.194.8.1123.
50. Eskandarian, H.A., Impens, F., Nahori, M.-A., Soubigou, G., Coppée, J.-Y., Cossart, et al. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science, 341, 2013, 1238858, 10.1126/science.1238858.
51. Esterhuyse, M.M., Weiner, J., Caron, E., Loxton, A.G., Iannaccone, M., Wagman, C.,.. Kaufmann, S.H.E., Epigenetics and proteomics join transcriptomics in the quest for tuberculosis biomarkers. mBio, 6(5), 2015, 10.1128/mBio.01187-15 e01187–15.
52. Falkenberg, K.J., Johnstone, R.W., Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 13:9 (2014), 673–691, 10.1038/nrd4360.
53. Fehri, L.F., Rechner, C., Janßen, S., Mak, T.N., Holland, C., Bartfeld, S., et al. Helicobacter pylori-induced modification of the histone H3 phosphorylation status in gastric epithelial cells reflects its impact on cell cycle regulation. Epigenetics 4 (2009), 577–586, 10.4161/epi.4.8.10217.
54. Foda, B.M., Singh, U., Dimethylated H3K27 is a repressive epigenetic histone mark in the Protist Entamoeba histolytica and is significantly enriched in genes silenced via the RNAi pathway. J Biol Chem 290:34 (2015), 21114–21130, 10.1074/jbc.M115.647263.
55. Foster, S.L., Medzhitov, R., Gene-specific control of the TLR-induced inflammatory response. Clin Immunol 130 (2009), 7–15, 10.1016/j.clim.2008.08.015.
56. Foster, S.L., Hargreaves, D.C., Medzhitov, R., Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447 (2007), 972–978, 10.1038/nature05836.
57. Friedman, J., Cho, W.-K., Chu, C.K., Keedy, K.S., Archin, N.M., Margolis, D.M., et al. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. J Virol 85:17 (2011), 9078–9089.
58. Fu, B., Tian, Z., Wei, H., Subsets of human natural killer cells and their regulatory effects. Immunology 141 (2014), 483–489, 10.1111/imm.12224.
59. Garcia-Garcia, J.C., Barat, N.C., Trembley, S.J., Dumler, J.S., Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog, 5(6), 2009, e1000488, 10.1371/journal.ppat.1000488.
60. Ghisletti, S., Barozzi, I., Mietton, F., Polletti, S., De Santa, F., Venturini, E., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32 (2010), 317–328, 10.1016/j.immuni.2010.02.008.
61. Ha, S.-D., Han, C.Y., Reid, C., Kim, S.O., HDAC8-mediated epigenetic reprogramming plays a key role in resistance to anthrax lethal toxin-induced pyroptosis in macrophages. J Immunol 193:3 (2014), 1333–1343, 10.4049/jimmunol.1400420.
62. Haigis, M.C., Sinclair, D.A., Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5 (2010), 253–295, 10.1146/annurev.pathol.4.110807.092250.
63. Hamon, M.A., Batsché, E., Régnault, B., Tham, T.N., Seveau, S., Muchardt, C., et al. Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci U S A 104 (2007), 13467–13472, 10.1073/pnas.0702729104.
64. Han, X., Li, X., Yue, S.C., Anandaiah, A., Hashem, F., Reinach, P.S.,.. Tachado, S.D., Epigenetic regulation of tumor necrosis factor α (TNFα) release in human macrophages by HIV-1 single-stranded RNA (ssRNA) is dependent on TLR8 signaling. J Biol Chem 287:17 (2012), 13778–13786, 10.1074/jbc.M112.342683.
65. Harouz, H., Rachez, C., Meijer, B.M., Marteyn, B., Donnadieu, F., Cammas, F.,.. Arbibe, L., Shigella flexneri targets the HP1γ subcode through the phosphothreonine lyase OspF. EMBO J 33:22 (2014), 2606–2622, 10.15252/embj.201489244.
66. He, M., Gao, S.-J., A novel role of SIRT1 in gammaherpesvirus latency and replication. Cell Cycle 13:21 (2014), 3328–3330, 10.4161/15384101.2014.968431.
67. Heerboth, S., Lapinska, K., Snyder, N., Leary, M., Rollinson, S., Sarkar, S., Use of epigenetic drugs in disease: an overview. Genet Epigenetics 6 (2014), 9–19, 10.4137/GEG.S12270.
68. Heintzman, N.D., Hon, G.C., Hawkins, R.D., Kheradpour, P., Stark, A., Harp, L.F., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459 (2009), 108–112, 10.1038/nature07829.
69. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P.,.. Glass, C.K., Simple combinations of lineage-determining TFs prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38:4 (2010), 576–589, 10.1016/j.molcel.2010.05.004.
70. Hilton, I.B., D'Ippolito, A.M., Vockley, C.M., Thakore, P.I., Crawford, G.E., Reddy, T.E., et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol 33 (2015), 510–517, 10.1038/nbt.3199.
71. Horwitz, G.A., Zhang, K., McBrian, M.A., Grunstein, M., Kurdistani, S.K., Berk, A.J., Adenovirus small e1a alters global patterns of histone modification. Science 321:5892 (2008), 1084–1085, 10.1126/science.1155544.
72. Ifrim, D.C., Quintin, J., Joosten, L.A.B., Jacobs, C., Jansen, T., Jacobs, L., et al. Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. Clin Vaccine Immunol, 2014, 10.1128/CVI.00688-13 00688-13.
73. Imai, K., Togami, H., Okamoto, T., Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 285:22 (2010), 16538–16545.
74. Ishii, M., Wen, H., Corsa, C.A.S., Liu, T., Coelho, A.L., Allen, R.M.,.. Kunkel, S.L., Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114:15 (2009), 3244–3254, 10.1182/blood-2009-04-217620.
75. Ivashkiv, L.B., Epigenetic regulation of macrophage polarization and function. Trends Immunol 34:5 (2013), 216–223, 10.1016/j.it.2012.11.001.
76. Jenuwein, T., Allis, C.D., Translating the histone code. Science 293 (2001), 1074–1080, 10.1126/science.1063127.
77. Kadioglu, A., Weiser, J.N., Paton, J.C., Andrew, P.W., The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6 (2008), 288–301, 10.1038/nrmicro1871.
78. Kaikkonen, M.U., Spann, N., Heinz, S., Romanoski, C.E., Allison, K.A., Stender, J.D.,.. Glass, C.K., Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell 51:3 (2013), 310–325, 10.1016/j.molcel.2013.07.010.
79. Kanno, Y., Vahedi, G., Hirahara, K., Singleton, K., O'Shea, J.J., Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 30 (2012), 707–731, 10.1146/annurev-immunol-020711-075058.
80. Kauder, S.E., Bosque, A., Lindqvist, A., Planelles, V., Verdin, E., Epigenetic regulation of HIV-1 latency by cytosine methylation S. Ross, ed. PLoS Pathog, 5(6), 2009 pp. e1000495–15.
81. Kearns, N.A., Pham, H., Tabak, B., Genga, R.M., Silverstein, N.J., Garber, M., Maehr, R., Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat Methods 12:5 (2015), 401–403, 10.1038/nmeth.3325.
82. Keedy, K.S., Archin, N.M., Gates, A.T., Espeseth, A., Hazuda, D.J., Margolis, D.M., A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J Virol 83:10 (2009), 4749–4756.
83. Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L.A.B., Ifrim, D.C., Saeed, S., et al. Bacille Calmette–Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 109 (2012), 17537–17542, 10.1073/pnas.1202870109.
84. Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L.A.B., Jacobs, C., Xavier, R.J., et al. BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin Immunol 155 (2014), 213–219, 10.1016/j.clim.2014.10.005.
85. Kouzarides, T., Histone methylation in transcriptional control. Curr Opin Genet Dev 12:2 (2002), 198–209.
86. Kouzarides, T., Chromatin modifications and their function. Cell 128:4 (2007), 693–705, 10.1016/j.cell.2007.02.005.
87. Kruidenier, L., Chung, C., Cheng, Z., Liddle, J., Che, K., Joberty, G., et al. A selective Jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488 (2012), 404–408, 10.1038/nature11262.
88. Kumar, A., Herbein, G., Epigenetic regulation of human cytomegalovirus latency: an update. Epigenomics 6:5 (2014), 533–546, 10.2217/epi.14.41.
89. Ledford, H., Epigenetics: the genome unwrapped. Nature 528:7580 (2015), S12–S13, 10.1038/528S12a.
90. Lee, J.Y., Kim, N.A., Sanford, A., Sullivan, K.E., Histone acetylation and chromatin conformation are regulated separately at the TNF-α promoter in monocytes and macrophages. J Leukoc Biol 73 (2003), 862–871, 10.1189/jlb.1202618.
91. Lee, G.R., Kim, S.T., Spilianakis, C.G., Fields, P.E., Flavell, R.A., T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24 (2006), 369–379, 10.1016/j.immuni.2006.03.007.
92. Lee, Y.K., Turner, H., Maynard, C.L., Oliver, J.R., Chen, D., Elson, C.O., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30 (2009), 92–107, 10.1016/j.immuni.2008.11.005.
93. Li, Y., Liu, B., Fukudome, E.Y., Kochanek, A.R., Finkelstein, R.A., Chong, W., et al. Surviving lethal septic shock without fluid resuscitation in a rodent model. Surgery 148 (2010), 246–254, 10.1016/j.surg.2010.05.003.
94. + T cells: differentiation and functions. Clin Dev Immunol, 2012, 2012, 925135, 10.1155/2012/925135.
95. Lugo-Villarino, G., Maldonado-Lopez, R., Possemato, R., Penaranda, C., Glimcher, L.H., T-bet is required for optimal production of IFN-γ and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A 100 (2003), 7749–7754, 10.1073/pnas.1332767100.
96. Lugrin, J., Ciarlo, E., Santos, A., Grandmaison, G., dos Santos, I., Le Roy, D., et al. The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock. Biochim Biophys Acta 1833 (2013), 1498–1510, 10.1016/j.bbamcr.2013.03.004.
97. Marazzi, I., Ho, J.S.Y., Kim, J., Manicassamy, B., Dewell, S., Albrecht, R.A.,.. Tarakhovsky, A., Suppression of the antiviral response by an influenza histone mimic. Nature 483:7390 (2012), 428–433, 10.1038/nature10892.
98. Maudet, C., Mano, M., Eulalio, A., MicroRNAs in the interaction between host and bacterial pathogens. FEBS Lett 588:22 (2014), 4140–4147, 10.1016/j.febslet.2014.08.002.
99. Medzhitov, R., Horng, T., Transcriptional control of the inflammatory response. Nat Rev Immunol 9 (2009), 692–703, 10.1038/nri2634.
100. Melichar, H.J., Narayan, K., Der, S.D., Hiraoka, Y., Gardiol, N., Jeannet, G., et al. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the TF SOX13. Science 315 (2007), 230–233, 10.1126/science.1135344.
101. Messi, M., Giacchetto, I., Nagata, K., Lanzavecchia, A., Natoli, G., Sallusto, F., Memory and flexibility of cytokine gene expression as separable properties of human TH1 and TH2 lymphocytes. Nat Immunol 4 (2003), 78–86, 10.1038/ni872.
102. Michalek, R.D., Gerriets, V.A., Jacobs, S.R., Macintyre, A.N., MacIver, N.J., Mason, E.F., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4 + T cell subsets. J Immunol 186 (2011), 3299–3303, 10.4049/jimmunol.1003613.
103. Modak, R., Das Mitra, S., Krishnamoorthy, P., Bhat, A., Banerjee, A., Gowsica, B.R., Kundu, T.K., Histone H3K14 and H4K8 hyperacetylation is associated with Escherichia coli-induced mastitis in mice. Epigenetics 7:5 (2012), 492–501, 10.4161/epi.19742.
104. Modak, R., Das Mitra, S., Vasudevan, M., Krishnamoorthy, P., Kumar, M., Bhat, A.V., Kundu, T.K., Epigenetic response in mice mastitis: role of histone H3 acetylation and microRNA(s) in the regulation of host inflammatory gene expression during Staphylococcus aureus infection. Clin Epigenetics, 6(1), 2014, 12, 10.1186/1868-7083-6-12.
105. Mombelli, M., Lugrin, J., Rubino, I., Chanson, A.-L., Giddey, M., Calandra, T., et al. Histone deacetylase inhibitors impair antibacterial defenses of macrophages. J Infect Dis 204 (2011), 1367–1374, 10.1093/infdis/jir553.
106. Moog, C., Kuntz-Simon, G., Caussin-Schwemling, C., Obert, G., Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol 77:Pt 9 (1996), 1993–1999.
107. Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8 (2008), 958–969, 10.1038/nri2448.
108. Mullican, S.E., Gaddis, C.A., Alenghat, T., Nair, M.G., Giacomin, P.R., Everett, L.J.,.. Lazar, M.A., Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev 25:23 (2011), 2480–2488, 10.1101/gad.175950.111.
109. Murray, P.J., Allen, J.E., Biswas, S.K., Fisher, E.A., Gilroy, D.W., Goerdt, S.,.. Wynn, T.A., Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:1 (2014), 14–20, 10.1016/j.immuni.2014.06.008.
110. Natoli, G., Maintaining cell identity through global control of genomic organization. Immunity 33:1 (2010), 12–24, 10.1016/j.immuni.2010.07.006.
111. Natoli, G., Ghisletti, S., Barozzi, I., The genomic landscapes of inflammation. Genes Dev 25 (2011), 101–106, 10.1101/gad.2018811.
112. Netea, M.G., Quintin, J., van der Meer, J.W.M., Trained immunity: a memory for innate host defense. Cell Host Microbe 9 (2011), 355–361, 10.1016/j.chom.2011.04.006.
113. Nicholas, D., Tang, H., Zhang, Q., Rudra, J., Xu, F., Langridge, W., et al. Quantitative proteomics reveals a role for epigenetic reprogramming during human monocyte differentiation. Mol Cell Proteomics, 2014, 10.1074/mcp.M113.035089.
114. Nicodeme, E., Jeffrey, K.L., Schaefer, U., Beinke, S., Dewell, S., Chung, C., et al. Suppression of inflammation by a synthetic histone mimic. Nature 468 (2010), 1119–1123, 10.1038/nature09589.
115. Nisole, S., Saïb, A., Early steps of retrovirus replicative cycle. Retrovirology, 1, 2004, 9, 10.1186/1742-4690-1-9.
116. O'Connor, C.M., DiMaggio, P.A., Shenk, T., Garcia, B.A., Quantitative proteomic discovery of dynamic epigenome changes that control human cytomegalovirus (HCMV) infection. Mol Cell Proteomics 13:9 (2014), 2399–2410, 10.1074/mcp.M114.039792.
117. O'Leary, J.G., Goodarzi, M., Drayton, D.L., von Andrian, U.H., T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7 (2006), 507–516, 10.1038/ni1332.
118. O'Neill, L.A.J., Hardie, D.G., Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493 (2013), 346–355, 10.1038/nature11862.
119. Oh, H.S., Traktman, P., Knipe, D.M., Barrier-to-autointegration factor 1 (BAF/BANF1) promotes association of the SETD1A histone methyltransferase with herpes simplex virus immediate-early gene promoters. mBio, 6(3), 2015, 10.1128/mBio.00345-15 e00345–00315.
120. Olins, D.E., Olins, A.L., Chromatin history: our view from the bridge. Nat Rev Mol Cell Biol 4 (2003), 809–814, 10.1038/nrm1225.
121. Ostuni, R., Piccolo, V., Barozzi, I., Polletti, S., Termanini, A., Bonifacio, S.,.. Natoli, G., Latent enhancers activated by stimulation in differentiated cells. Cell 152:1–2 (2013), 157–171, 10.1016/j.cell.2012.12.018.
122. Pacis, A., Tailleux, L., Morin, A.M., Lambourne, J., Maclsaac, J.L., Yotova, V.,.. Barreiro, L.B., Bacterial infection remodels the DNA methylation landscape of human dendritic cells. Genome Res, 2015, 10.1101/gr.192005.115 gr.192005.115.
123. Papanicolaou, K.N., O'Rourke, B., Foster, D.B., Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria. Front Physiol, 5, 2014, 10.3389/fphys.2014.00301.
124. Park, J., Chen, Y., Tishkoff, D.X., Peng, C., Tan, M., Dai, L., et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell 50 (2013), 919–930, 10.1016/j.molcel.2013.06.001.
125. Pathak, S.K., Basu, S., Bhattacharyya, A., Pathak, S., Banerjee, A., Basu, J., et al. TLR4-dependent NF-κB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol 177 (2006), 7950–7958, 10.4049/jimmunol.177.11.7950.
126. Pearson, R., Kim, Y.K., Hokello, J., Lassen, K., Friedman, J., Tyagi, M., Karn, J., Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J Virol 82:24 (2008), 12291–12303.
127. Pirone-Davies, C., Hoffmann, M., Roberts, R.J., Muruvanda, T., Timme, R.E., Strain, E., Allard, M.W., Genome-wide methylation patterns in Salmonella enterica subsp. enterica Serovars. PLoS One, 10(4), 2015, e0123639, 10.1371/journal.pone.0123639.
128. Prince, H.M., Bishton, M.J., Panobinostat (LBH589): a novel pan-deacetylase inhibitor with activity in T cell lymphoma. Haematol Meet Rep 3:1 (2009), 33–38.
129. Quintin, J., Saeed, S., Martens, J.H.A., Giamarellos-Bourboulis, E.J., Ifrim, D.C., Logie, C., et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12 (2012), 223–232, 10.1016/j.chom.2012.06.006.
130. Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A., Wysocka, J., A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470:7333 (2011), 279–283, 10.1038/nature09692.
131. Rahman, S., Sowa, M.E., Ottinger, M., Smith, J.A., Shi, Y., Harper, J.W., et al. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3 ▿. Mol Cell Biol 31 (2011), 2641–2652, 10.1128/MCB.01341-10.
132. Rajaram, M.V.S., Ni, B., Morris, J.D., Brooks, M.N., Carlson, T.K., Bakthavachalu, B.,.. Schlesinger, L.S., Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci 108:42 (2011), 17408–17413, 10.1073/pnas.1112660108.
133. Rasmussen, T.A., Schmeltz Søgaard, O., Brinkmann, C., Wightman, F., Lewin, S.R., Melchjorsen, J., et al. Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation. Hum Vaccines Immunotherapeutics 9:5 (2013), 993–1001.
134. Rasmussen, T.A., Tolstrup, M., Brinkmann, C.R., Olesen, R., Erikstrup, C., Solomon, A., et al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial. Lancet HIV 1:1 (2014), e13–e21.
135. Rennoll-Bankert, K.E., Garcia-Garcia, J.C., Sinclair, S.H., Dumler, J.S., Chromatin-bound bacterial effector ankyrin A recruits histone deacetylase 1 and modifies host gene expression. Cell Microbiol 17:11 (2015), 1640–1652, 10.1111/cmi.12461.
136. Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J.-S., Quivy, V., et al. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection P. Sommer, ed. PLoS One, 4(6), 2009 pp. e6093–19.
137. Robins, H.S., Campregher, P.V., Srivastava, S.K., Wacher, A., Turtle, C.J., Kahsai, O., et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114 (2009), 4099–4107, 10.1182/blood-2009-04-217604.
138. Roger, T., Lugrin, J., Roy, D.L., Goy, G., Mombelli, M., Koessler, T., et al. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117 (2011), 1205–1217, 10.1182/blood-2010-05-284711.
139. Roh, T.-Y., Cuddapah, S., Cui, K., Zhao, K., The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci 103 (2006), 15782–15787.
140. Rolando, M., Sanulli, S., Rusniok, C., Gomez-Valero, L., Bertholet, C., Sahr, T., et al. Legionella pneumophila effector RomA uniquely modifies host chromatin to repress gene expression and promote intracellular bacterial replication. Cell Host Microbe 13 (2013), 395–405, 10.1016/j.chom.2013.03.004.
141. Rothenberg, E.V., Transcriptional control of early T and B cell developmental choices. Annu Rev Immunol 32 (2014), 283–321, 10.1146/annurev-immunol-032712-100024.
142. Saeed, S., Quintin, J., Kerstens, H.H.D., Rao, N.A., Aghajanirefah, A., Matarese, F., et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science, 345, 2014, 1251086, 10.1126/science.1251086.
143. Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., et al. The Jmjd3–Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11 (2010), 936–944, 10.1038/ni.1920.
144. Schmidl, C., Renner, K., Peter, K., Eder, R., Lassmann, T., Balwierz, P.J., et al., FANTOM consortium, Transcription and enhancer profiling in human monocyte subsets. Blood 123 (2014), e90–e99, 10.1182/blood-2013-02-484188.
145. Schnitger, A.K.D., Machova, A., Mueller, R.U., Androulidaki, A., Schermer, B., Pasparakis, M.,.. Papadopoulou, N., Listeria monocytogenes infection in macrophages induces vacuolar-dependent host miRNA response. PLoS One, 6(11), 2011, e27435, 10.1371/journal.pone.0027435.
146. Shahbazian, M.D., Grunstein, M., Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76 (2007), 75–100, 10.1146/annurev.biochem.76.052705.162114.
147. Shi, C., Pamer, E.G., Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11 (2011), 762–774, 10.1038/nri3070.
148. Shih, J., Donmez, G., Mitochondrial sirtuins as therapeutic targets for age-related disorders. Genes Cancer 4:3–4 (2013), 91–96, 10.1177/1947601912474931.
149. Siliciano, J.D., et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 + T cells. Nat Med 9:6 (2003), 727–728.
150. Smale, S.T., Selective transcription in response to an inflammatory stimulus. Cell 140 (2010), 833–844, 10.1016/j.cell.2010.01.037.
151. Smale, S.T., Tarakhovsky, A., Natoli, G., Chromatin contributions to the regulation of innate immunity. Annu Rev Immunol 32 (2014), 489–511, 10.1146/annurev-immunol-031210-101303.
152. Staedel, C., Darfeuille, F., MicroRNAs and bacterial infection. Cell Microbiol 15:9 (2013), 1496–1507, 10.1111/cmi.12159.
153. Taganov, K.D., Boldin, M.P., Chang, K.-J., Baltimore, D., NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci 103:33 (2006), 12481–12486, 10.1073/pnas.0605298103.
154. Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-McDermott, E.M., McGettrick, A.F., Goel, G., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496 (2013), 238–242, 10.1038/nature11986.
155. Tanuchi, I., Osato, M., Egawa, T., Sunshine, M.J., Bae, S.C., Komori, T., Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111 (2002), 621–633.
156. Tsuji, M., Komatsu, N., Kawamoto, S., Suzuki, K., Kanagawa, O., Honjo, T., et al. Preferential generation of follicular B helper T cells from Foxp3 + T cells in gut Peyer's patches. Science 323 (2009), 1488–1492, 10.1126/science.1169152.
157. Twigg, H.L., Macrophages in innate and acquired immunity. Semin Respir Crit Care Med 25 (2004), 21–31, 10.1055/s-2004-822302.
158. Verdin, E., The many faces of sirtuins: coupling of NAD metabolism, sirtuins and lifespan. Nat Med 20:1 (2014), 25–27, 10.1038/nm.3447.
159. Verdin, E., Paras, P., Van Lint, C., Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12:8 (1993), 3249–3259.
160. Vishwakarma, S., Iyer, L.R., Muley, M., Singh, P.K., Shastry, A., Saxena, A.,.. Narayanan, S., Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects. Int Immunopharmacol 16:1 (2013), 72–78, 10.1016/j.intimp.2013.03.016.
161. Wang, Y., Curry, H.M., Zwilling, B.S., Lafuse, W.P., Mycobacteria inhibition of IFN-γ induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J Immunol 174:9 (2005), 5687–5694, 10.4049/jimmunol.174.9.5687.
162. Webby, C.J., Wolf, A., Gromak, N., Dreger, M., Kramer, H., Kessler, B., et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 325 (2009), 90–93, 10.1126/science.1175865.
163. Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4 + T cells. Immunity 30 (2009), 155–167, 10.1016/j.immuni.2008.12.009.
164. Weinmann, A.S., Mitchell, D.M., Sanjabi, S., Bradley, M.N., Hoffmann, A., Liou, H.C., et al. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat Immunol 2 (2001), 51–57, 10.1038/83168.
165. Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., Bui, T.V., Cross, J.R., Thompson, C.B., ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 (2009), 1076–1080, 10.1126/science.1164097.
166. Wheeler, D.S., Lahni, P.M., Denenberg, A.G., Poynter, S.E., Wong, H.R., Cook, J.A., et al. Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 30 (2008), 267–273, 10.1097/shk.0b013e318162c190.
167. Williams, S.A., Chen, L.-F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., et al. Prostratin antagonizes HIV latency by activating NF-kappaB. J Biol Chem 279:40 (2004), 42008–42017.
168. Witvrouw, M., et al. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retrovir 13:2 (1997), 187–192.
169. Xu, L., Kitani, A., Fuss, I., Strober, W., Cutting edge: regulatory T cells induce CD4 + CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 1950:178 (2007), 6725–6729.
170. Yáñez, A., Hassanzadeh-Kiabi, N., Ng, M.Y., Megías, J., Subramanian, A., Liu, G.Y., et al. Detection of a TLR2 agonist by hematopoietic stem and progenitor cells impacts the function of the macrophages they produce. Eur J Immunol 43 (2013), 2114–2125, 10.1002/eji.201343403.
171. Yang, X.O., Pappu, B.P., Nurieva, R., Akimzhanov, A., Kang, H.S., Chung, Y., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28 (2008), 29–39, 10.1016/j.immuni.2007.11.016.
172. Yaseen, I., Kaur, P., Nandicoori, V.K., Khosla, S., Mycobacteria modulate host epigenetic machinery by Rv1988 methylation of a non-tail arginine of histone H3. Nat Commun, 6, 2015, 8922, 10.1038/ncomms9922.
173. Yoneyama, M., Fujita, T., Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 282 (2007), 15315–15318, 10.1074/jbc.R700007200.
174. Zhang, Z., Li, Z., Gao, C., Chen, P., Chen, J., Liu, W.,.. Lu, H., miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Investig 88:12 (2008), 1358–1366, 10.1038/labinvest.2008.94.
175. Zhao, T., Li, Y., Liu, B., Halaweish, I., Mazitschek, R., Alam, H.B., Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model. J Surg Res 190 (2014), 647–654, 10.1016/j.jss.2014.01.056.
176. Zou, Y.-R., Sunshine, M.-J., Taniuchi, I., Hatam, F., Killeen, N., Littman, D.R., Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat Genet 29 (2001), 332–336, 10.1038/ng750.